Hcspcs fosphenytoin
WebNDC 63323-403-02 400302 FOSPHENYTOIN SODIUM INJECTION, USP 100 mg PE/2 mL (50 mg PE/mL) (PE = phenytoin sodium equivalents) For IM or IV use RX only … WebFosphenytoin is an antiepileptic agent used for the management of generalized convulsive status epilepticus and prevention and treatment of seizures occurring during neurosurgery. Brand Names Cerebyx, Sesquient Generic Name Fosphenytoin DrugBank Accession Number DB01320 Background
Hcspcs fosphenytoin
Did you know?
WebApr 1, 2024 · Manufacturers of Fosphenytoin that have been granted an NDC (National Drug Code). WebHCPCS Code. S0078. Injection, fosphenytoin sodium, 750 mg. Commercial Payers (Temporary Codes) S0078 is a valid 2024 HCPCS code for Injection, fosphenytoin …
WebMar 30, 2024 · Fosphenytoin Sodium - NDC drug/product. NDCs and labelers of "Fosphenytoin Sodium": NDC Trade Name Labeler Name; 00517-6902: Fosphenytoin Sodium: American Regent, Inc. 65162-0998: Fosphenytoin Sodium: ... AHA Coding Clinic ® for HCPCS - current + archives AHA Coding Clinic ... Webdecreases as total fosphenytoin concentrations increase. Fosphenytoin displaces phenytoin from protein binding sites. The volume of distribution of fosphenytoin increases with CEREBYX dose and rate, and ranges from 4.3 to 10.8 liters. Metabolism and Elimination: The conversion half-life of fosphenytoin to phenytoin is approximately 15 …
WebThe Healthcare Common Procedure Coding System (HCPCS) is a collection of codes that represent procedures, supplies, products and services which may be provided to … WebApr 1, 2024 · Fosphenytoin injection is used to control certain types of seizures (convulsions) in the treatment of epilepsy. It is also used to prevent and treat seizures that occur during brain surgery. This medicine is an anticonvulsant that works in the brain tissue to stop seizures.
WebFosphenytoin. Fosphenytoin is a disodium phosphate ester of 3-hydroxy-methyl-5,5 diphenylhydantoin, which is rapidly and completely converted to phenytoin (conversion half-life, 8–15 minutes). It was approved for the treatment of SE in the USA in 1996. It is metabolized by the liver and has a half-life of 14 hours.
WebJan 1, 2000 · HCPCS Coverage Code: A code denoting Medicare coverage status. HCPCS Action Code: A code denoting the change made to a procedure or modifier code within … hepatiitti c hoitoWebHCPCS CODE HCPCS DESCRIPTION/GENERIC NAME HEMOPHILIA, VON WILLEBRAND DISEASE, & RELATED BLEEDING DISORDERS Advate J7192 Factor VIII (antihemophilic factor, recombinant) per IU Alphanate J7186 Injection, antihemophilic factor VIII/von Willebrand factor complex (human) per factor VIII i.u. hepatiitti c lääkehoitoWebNov 8, 2024 · Fosphenytoin is available in parenteral formulations in 2 and 10 mL vials in concentrations of 50 mg/mL generically and under the brand name Cerebyx. The recommended dose in adults is a loading dose of 10 … hepatiitti c tarttuminenWebHCPCS Code. Q2009. Injection, fosphenytoin, 50 mg phenytoin equivalent. Miscellaneous Services (Temporary Codes) Q2009 is a valid 2024 HCPCS code for Injection, fosphenytoin, 50 mg phenytoin equivalent or just “ Fosphenytoin inj pe ” for short, … hepatiitti oireetWebCEREBYX® (fosphenytoin sodium injection) is a prodrug intended for parenteral administration; its active metabolite is phenytoin. 1.5 mg of fosphenytoin sodium is equivalent to 1 mg phenytoin sodium, and is referred to as 1 mg phenytoin sodium equivalents (PE). The amount and concentration of fosphenytoin is always expressed in … hepatiitti rokote oireetWebFosphenytoin sodium injection, USP is a prodrug intended for parenteral administration; its active metabolite is phenytoin. Each fosphenytoin sodium injection vial contains 75 mg/mL fosphenytoin sodium (hereafter referred to as fosphenytoin) equivalent to 50 mg/mL phenytoin sodium after administration. Fosphenytoin sodium injection hepatiittirokote thlWebNov 30, 2024 · The much-awaited ESETT trial is a multi-center RCT comparing three anti-epileptic agents for ongoing status epilepticus (levetiracetam, fosphenytoin, and valproate). This trial will be the … hepatiitti c rokote